Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients With Bronchiectasis

Bronchiectasis Adult Clinical Trial

Official title:

Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients With Bronchiectasis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04744220
• Other study ID #: 10840098-604.01.01-E.19408
• Status: Completed
• Phase: N/A
• Start date: November 25, 2020
• Est. completion date: December 30, 2022

Study information

• Verified date: October 2022
• Source: Istanbul Medipol University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients with Bronchiectasis between the ages of 30-55

Description:

Investigating the effect of yoga training on functional capacity and quality of life and comparing with previous studies

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 30, 2022
• Est. primary completion date: November 20, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 55 Years

Eligibility

Inclusion Criteria:

• Diagnosed with bronchiectasis

• Age 30-55

• Not having a known systemic, orthopedic or neurological disease

Exclusion Criteria:

• Severe heart failure

• People who had an acute exacerbation up to three weeks ago will not be included in the study

Related Conditions & MeSH terms

• Bronchiectasis
• Bronchiectasis Adult

Intervention

Other:
• Yoga Training Program (exercises)
Training: Before the yoga program, the patients will be informed about the bronchiectasis disease and its symptoms, as well as all the parameters used in the evaluation, tests and the content of the yoga session. The patients will start with breathing exercises, then relaxation exercises, warm-up exercises, asanas (posture exercises) and finally the yoga training program will be completed with deep relaxation technique.

Locations

Country	Name	City	State
Turkey	Istanbul Medipol University Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medipol University Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Respiratory Function Test	A spirometer will be used to evaluate the lung function of individuals. It will be expressed as a percentage of the expected values by age, height, body weight and gender.	Before and after treatment( 8 week )
Other	Quality of Life Assessment	Quality of life, St. George's Respiratory Questionnaire (SGRQ). SGRQ is a health-related quality of life questionnaire that questions a total of 50 items under 3 main components: symptoms (8 items), activity (16 items) and effects of disease (26 items). The symptoms component includes the frequency and duration of symptoms such as cough, sputum, shortness of breath, wheezing.; The activity component relates to physical activities that are restricted due to shortness of breath. It includes factors such as the effects component of the disease, the drugs used and its side effects, the individual's expectations for health and the discomfort they face in daily life. The total score is between 0-100. The higher the score, the lower the quality of life	Before and after treatment (8 week)
Other	Evaluation of Functional Capacity	Individuals' functional capacity will be evaluated with the six-minute walking test (6MWT). During the 6MWT, individuals are asked to walk in a straight corridor of 30 meters as fast as possible, at their own walking pace in standard directions.; At the end of the test, the walking distance is recorded in meters.	Before and after treatment (8 week)
Other	Assessment of Sleep Quality	Pittsburgh Sleep Quality Index (PSQI) will be used to evaluate the sleep quality of the individuals participating in our study before and after the 8-week study period.; PSQI is a test that plays a role in determining sleep quality and sleep-related disorders in the last month. It is a scale consisting of 19 self-report items, a total of 24 questions with a score range of 0-21, and the remaining five questions must be answered by a roommate or a spouse. It is a test that evaluates a wide variety of areas related to sleep quality, including components, sleep time, delays in falling asleep, the frequency and severity of sleep-related problems, and the impact of poor sleep on an individual's work.	Before and after treatment (8 week)
Primary	Patient Follow-up Form	The demographic characteristics, physical characteristics such as age, height and body weight of the individuals included in the study and their education status will be recorded.	Baseline
Secondary	Dyspnea Assessment	Dyspnea will be assessed by the modified Medical Research Council (MMRC) dyspnea scale. Individuals will be asked to choose the statement that best describes their dyspnea level.; Scoring in MMRC varies between 0-4 points. "0 points" means that there is no dyspnea; "4 points" indicates a perception of dyspnea during basic daily life activities such as dressing.	Before and after treatment (8 week)